Grace Therapeutics (GRCE) Share-based Compensation (IS) (2024 - 2026)
Grace Therapeutics' Share-based Compensation (IS) was $105,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 65.2% from $302,000 a year earlier and down 42.3% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Grace Therapeutics' Share-based Compensation (IS) was $602,000 through Jun 30, 2026, down 24.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was $798,000, up 9.3% from FY2025.
- In earlier fiscal years, Share-based Compensation (IS) was $730,000 in FY2025 (-20.0%) and $913,000 in FY2024.
- The fiscal Q1 2027 figure marks the lowest quarterly Share-based Compensation (IS) in data going back to fiscal Q1 2025.
- Compared with a year earlier, Share-based Compensation (IS) was higher in three of the last five quarters, with an average decline of 5.6%.
- Per Business Quant data, GRCE's Share-based Compensation (IS) in the three fiscal quarters before Q1 2027 was $182,000 (Q4 2026), $109,000 (Q3 2026) and $206,000 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Grace Therapeutics | 34.50 Mn | 34.50 Mn | - | 105,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 105,000.00 |
| Mar 31, 2026 | 182,000.00 |
| Dec 31, 2025 | 109,000.00 |
| Sep 30, 2025 | 206,000.00 |
| Jun 30, 2025 | 302,000.00 |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | 202,000.00 |
| Jun 30, 2024 | 238,000.00 |
API Access
Grace Therapeutics Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();